ALS vs Parkinson’s Disease: Key Differences Every Family Should Know

Amyotrophic Lateral Sclerosis (ALS) and Parkinson’s disease are two of the most well-known neurodegenerative conditions, and they are frequently confused by patients and families. Both affect movement, both progress over time, and both present daunting challenges for those diagnosed. But beneath these surface similarities lie fundamentally different diseases requiring very different approaches to care.

The Core Difference: Which Neurons Are Affected?

The most important distinction is which parts of the nervous system each disease targets:

ALS (Lou Gehrig’s Disease): Attacks motor neurons in the brain and spinal cord — the nerve cells that control voluntary muscle movement. As motor neurons die, muscles progressively weaken, waste away, and eventually stop functioning.

Parkinson’s Disease: Targets dopamine-producing neurons in the basal ganglia, specifically the substantia nigra region. The loss of dopamine disrupts the brain’s signals for coordinated movement, but the muscles themselves remain structurally intact.

As researchers at the Proteostasis and Movement Disorders lab noted in a published comparison: Parkinson’s is the second most common neurodegenerative disease after Alzheimer’s, affecting over one million people in the U.S. ALS, while less prevalent with around 30,000 cases in the United States, has an annual incidence closer to Parkinson’s — the much lower prevalence is due to its rapid progression to mortality, typically 3–4 years post-diagnosis compared to approximately 20 years for PD.

Symptoms: How They Present Differently

Parkinson’s Disease Symptoms

• Resting tremor (shaking when the hands are still)

• Muscle rigidity and stiffness

• Bradykinesia (slowness of movement)

• Postural instability and shuffling gait

• Non-motor symptoms: depression, sleep disturbances, cognitive changes

ALS Symptoms

• Progressive muscle weakness and atrophy

• Muscle twitching (fasciculations)

• Difficulty speaking, swallowing, and breathing

• No tremors (unlike Parkinson’s)

• Cognitive function usually preserved until late stages

Progression and Prognosis

The trajectory of these two diseases is starkly different. ALS is aggressive, often leading to severe disability within a few years and typically progressing to respiratory failure. The average survival from symptom onset is 3–10 years, though some patients live longer.

Parkinson’s disease, by contrast, typically progresses slowly over decades. With modern treatments, many patients live 15–20 years or longer after diagnosis. The disease is not directly fatal; rather, complications such as pneumonia and falls are the primary threats in advanced stages.

Treatment Approaches

For Parkinson’s: Treatment centers on restoring dopamine function through medications (levodopa, dopamine agonists), physical therapy, and in some cases, deep brain stimulation (DBS) surgery. Emerging VR-based rehabilitation approaches are showing particular promise for balance training and motor function improvement.

For ALS: There is currently no cure. Treatment focuses on symptom management and quality of life through medications like riluzole and edaravone, physical therapy, speech therapy, respiratory support, and adaptive equipment as the disease progresses.

Can You Have Both?

Interestingly, research published in ACS Chemical Neuroscience has documented the Brait–Fahn–Schwartz disease, first described approximately 50 years ago, characterized by the coexistence of ALS and Parkinson’s disease. Population-based studies have demonstrated that about one-third of ALS patients develop parkinsonian signs, even though different neuronal circuitries are involved.

If you or a loved one is navigating Parkinson’s disease, SparshMind’s VR physiotherapy programs can help maintain mobility and quality of life. Our evidence-based VR rehabilitation is designed specifically for neurological conditions.

📞 Personalized Neurological Rehabilitation

SparshMind offers VR-based physiotherapy programs tailored to patients with Parkinson’s disease and other neurological conditions. Contact us to discuss how our approach can support your rehabilitation goals.

References

1. Medical News Today. “ALS vs. Parkinson’s disease: Differences and more.” medicalnewstoday.com/articles/als-vs-parkinsons

2. PMC. “Proteostasis and Movement Disorders: Parkinson’s Disease and Amyotrophic Lateral Sclerosis.” pmc.ncbi.nlm.nih.gov/articles/PMC3179340/

3. ACS Chemical Neuroscience (2024). “Shared and Unique Disease Pathways in ALS and Parkinson’s Disease.” pubs.acs.org/doi/10.1021/acschemneuro.3c00629

4. ALS United North Carolina. “ALS vs. Other Neurodegenerative Diseases.” alsnc.org/als-vs-other-neurodegenerative-diseases/

5. MediSearch. “Parkinson’s Disease vs ALS: Key Differences and Similarities.” medisearch.io/blog/als-vs-parkinsons